<?xml version="1.0" encoding="UTF-8"?>
<p>Though often assumed benign, it is increasingly recognized that for many pathogens, clinically inapparent infections can represent a sizeable portion of the infectious reservoir [
 <xref rid="ppat.1006965.ref001" ref-type="bibr">1</xref>â€“
 <xref rid="ppat.1006965.ref003" ref-type="bibr">3</xref>] and contribute substantially to pathogen transmission [
 <xref rid="ppat.1006965.ref004" ref-type="bibr">4</xref>]. Understanding the contribution to transmission from people with inapparent infections is fundamental for inferring drivers of transmission [
 <xref rid="ppat.1006965.ref003" ref-type="bibr">3</xref>], estimating the timing and scope of outbreaks [
 <xref rid="ppat.1006965.ref005" ref-type="bibr">5</xref>], planning and monitoring control efforts [
 <xref rid="ppat.1006965.ref006" ref-type="bibr">6</xref>], and assessing the feasibility of pathogen elimination [
 <xref rid="ppat.1006965.ref001" ref-type="bibr">1</xref>,
 <xref rid="ppat.1006965.ref006" ref-type="bibr">6</xref>].
</p>
